Selected Start-Ups (05/2010)
In Vivo briefly describes these recently founded companies: Avraham Pharmaceuticals, LipimetiX, Nautilus Neurosciences, NovaTract Surgical, SpineGuard and Thrombologic.
You may also be interested in...
American Injectables plans to build up its US-based manufacturing after securing a commitment for $10m of ‘Series A’ financing from New Rhein Healthcare Investors, which it will use to scale up production and launch several generic parenteral products.
A draft EU guideline explains how disease registries can be used to supplement evidence in the pre-authorization phase and provide infrastructure for post-authorization evidence generation.
Drug companies have their last chance to negotiate which documents and information Italy’s regulator, AIFA, will be entitled to request of them when they submit pricing and reimbursement applications.